doi: 10.1016/j.bcp.2021.114693 Redd, Meredith A., Scheuer, Sarah E., Saez, Natalie J., Yoshikawa, Yusuke, Chiu, Han Sheng, Gao, Ling, Hicks, Mark, Villanueva, Jeanette E., Joshi, Yashutosh, Chow, Chun Yuen, Cuellar-Partida, Gabriel, Peart, Jason N., See Hoe, Louise E., Chen, Xiaoli, Sun, Yuliangzi, Suen, Jacky Y., Hatch, Robert J., Rollo, Ben, Xiao, Di, Alzubaidi, Mubarak A.H., Maljevic, Snezana, Quaife-Ryan, Gregory A., Hudson, James E., Porrello, Enzo R., White, Melanie Y., Cordwell, Stuart J., Fraser, John F., Petrou, Steven, Reichelt, Melissa E
The biomarkers which had the effect sizes that were significant comprised of 28 biomarkers which are in descending order of the effect size given as: CTPN (SMD 37.93, p = 0.03), TG (SMD 16.60, p = 0.0007), BG (SMD 7.54, p = 0.00001), TC (SMD 7.38, p = 0.009), HDL (SMD -5.84, p= 0.0002), LDH (SMD 5.66, p = 0.0005), IL-6 (SMD 5.49, p = 0.00001), AGEs (SMD 5.43, p = 0.004), MDA (SMD 4.78, p = 0.00001), HW (SMD 4.73, p = 0.05), GSH (SMD -4.60, p = 0.009), IL-1 (SMD 4.44, p = 0.003), EF% (SMD -4.13, p = 0.00001), CC3 (SMD 3.91, p = 0.002), NLRP3 (SMD 3.59, p= 0.03), CK-MB (SMD 3.28, p = 0.004), FB% (SMD 3.25, p = 0.01), NF-KB (SMD 3.13, p = 0.0001), HMGB1 (SMD 3.00, p = 0.0001), FS% (SMD -2.91, p= 0.00001), COL III (SMD 2.43, p = 0.01), TLR4 (SMD 2.38, p = 0.009), HW/BW (SMD 2.31, p = 0.007), pJNK (SMD 1.87, p = 0.0001), BW (SMD -1.74, p= 0.05), LVIDs (SMD 1.64, p = 0.04), TGF-1 (SMD 1.50, p = 0.05), and TNF-A (SMD 1.11, p = 0.03)
The presence of neurological complications substantially affects response time
Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia
ADOS ADI-R, CARS, CBCL, PLS, SCQ and MSEL
See our affiliate policy for details
